Research Article

ABO Blood Groups and Upper Gastrointestinal Bleeding: A Five-Year Retrospective Study

Volume: 14 Number: 3 December 30, 2025

ABO Blood Groups and Upper Gastrointestinal Bleeding: A Five-Year Retrospective Study

Abstract

Objective: Upper gastrointestinal bleeding (UGIB) is a life-threatening emergency associated with significant mortality, necessitating the identification of reliable prognostic factors. Although ABO blood groups have been linked to bleeding tendencies, their role in the prognosis of UGIB remains unclear. This study aimed to investigate the association between ABO blood groups and mortality in patients with UGIB, as well as their relationship with other clinical outcomes. Materials and Methods: In this retrospective cohort study, data from 992 adult patients (≥18 years) diagnosed with UGIB at Marmara University Pendik Training and Research Hospital Emergency Department between 2018 and 2022 were analyzed. Patients discharged against medical advice or with incomplete records were excluded. Data on ABO/Rh blood groups, comorbidities, mortality, blood transfusion requirements, and length of hospital stay were extracted from hospital records. Results: Among 992 patients (median age 67 years; 64.2% male), the overall in-hospital mortality rate was 12.7% (126/992). Mortality rates were 11.0% in group O, 13.0% in group A, 14.6% in group B, and 15.9% in group AB, with no statistically significant differences (p = 0.572). Logistic regression analysis showed no significant association between blood groups and mortality: group A (OR: 1.210 (95% CI: 0.784–1.868); p = 0.389), group B (OR: 1.379 (95% CI: 0.782–2.432); p = 0.267), and group AB (OR: 1.524 (95% CI: 0.719–3.230); p = 0.272) compared with group O. No significant differences were observed between O and non-O groups in terms of transfusion requirement (OR: 1.06 (95% CI: 0.804–1.39); p = 0.697), hospital stay duration (p = 0.114), or endoscopic stigmata distribution (p = 0.894). Conclusion: ABO blood groups were not found to be independent predictors of mortality or other clinical outcomes in UGIB patients. Although the proportion of group O patients was higher among those with UGIB, blood group-based risk stratification appears to have limited prognostic value. These findings support prioritizing broader clinical factors in the management of UGIB.

Keywords

References

  1. Chen L, Zheng H, Wang S. Prediction model of emergency mortality risk in patients with acute upper gastrointestinal bleeding: a retrospective study. PeerJ. 2021;9:e11656.
  2. Kudu E, Danış F. The evolution of gastrointestinal bleeding: a holistic investigation of global outputs with bibliometric analysis. Turk J Gastroenterol. 2022;33(12):1012–1024.
  3. Kamboj AK, Hoversten P, Leggett CL. Upper gastrointestinal bleeding: etiologies and management. Mayo Clin Proc. 2019;94(4):697–703.
  4. Kudu E, Danış F. Recognizing and addressing the challenges of gastrointestinal tuberculosis. World J Clin Cases. 2024;12(19):3648–3653.
  5. Kudu E, Altun M, Ucar AB, et al. Factors associated with thirty-day emergency department revisits for upper gastrointestinal bleeding: insights from a five-year retrospective study. Anatolian J Emerg Med. 2025;8(1).
  6. Baumbach R, Faiss S, Cordruwisch W, Schrader C. [Acute gastrointestinal bleeding]. Dtsch Med Wochenschr. 2016;141(8):561–568; quiz 569–570.
  7. Orpen-Palmer J, Stanley A. A review of risk scores within upper gastrointestinal bleeding. J Clin Med. 2023;12(11):3678.
  8. Bayan K, Tüzün Y, Yılmaz Ş, Dursun M, Canoruç F. Clarifying the relationship between ABO/Rhesus blood group antigens and upper gastrointestinal bleeding. Dig Dis Sci. 2009;54(5):1029–1034.

Details

Primary Language

English

Subjects

Emergency Medicine, ​Internal Diseases

Journal Section

Research Article

Publication Date

December 30, 2025

Submission Date

July 28, 2025

Acceptance Date

September 13, 2025

Published in Issue

Year 2025 Volume: 14 Number: 3

APA
Altun, M., Kudu, E., Tiriş, C., Uçar, A. B., Karacabey, S., Sanrı, E., Onur, Ö. E., & Denizbaşı, A. (2025). ABO Blood Groups and Upper Gastrointestinal Bleeding: A Five-Year Retrospective Study. Abant Medical Journal, 14(3), 186-193. https://doi.org/10.47493/abantmedj.1752485
AMA
1.Altun M, Kudu E, Tiriş C, et al. ABO Blood Groups and Upper Gastrointestinal Bleeding: A Five-Year Retrospective Study. Abant Med J. 2025;14(3):186-193. doi:10.47493/abantmedj.1752485
Chicago
Altun, Mustafa, Emre Kudu, Cansu Tiriş, et al. 2025. “ABO Blood Groups and Upper Gastrointestinal Bleeding: A Five-Year Retrospective Study”. Abant Medical Journal 14 (3): 186-93. https://doi.org/10.47493/abantmedj.1752485.
EndNote
Altun M, Kudu E, Tiriş C, Uçar AB, Karacabey S, Sanrı E, Onur ÖE, Denizbaşı A (December 1, 2025) ABO Blood Groups and Upper Gastrointestinal Bleeding: A Five-Year Retrospective Study. Abant Medical Journal 14 3 186–193.
IEEE
[1]M. Altun et al., “ABO Blood Groups and Upper Gastrointestinal Bleeding: A Five-Year Retrospective Study”, Abant Med J, vol. 14, no. 3, pp. 186–193, Dec. 2025, doi: 10.47493/abantmedj.1752485.
ISNAD
Altun, Mustafa - Kudu, Emre - Tiriş, Cansu - Uçar, Asli Bahar - Karacabey, Sinan - Sanrı, Erkman - Onur, Özge Ecmel - Denizbaşı, Arzu. “ABO Blood Groups and Upper Gastrointestinal Bleeding: A Five-Year Retrospective Study”. Abant Medical Journal 14/3 (December 1, 2025): 186-193. https://doi.org/10.47493/abantmedj.1752485.
JAMA
1.Altun M, Kudu E, Tiriş C, Uçar AB, Karacabey S, Sanrı E, Onur ÖE, Denizbaşı A. ABO Blood Groups and Upper Gastrointestinal Bleeding: A Five-Year Retrospective Study. Abant Med J. 2025;14:186–193.
MLA
Altun, Mustafa, et al. “ABO Blood Groups and Upper Gastrointestinal Bleeding: A Five-Year Retrospective Study”. Abant Medical Journal, vol. 14, no. 3, Dec. 2025, pp. 186-93, doi:10.47493/abantmedj.1752485.
Vancouver
1.Mustafa Altun, Emre Kudu, Cansu Tiriş, Asli Bahar Uçar, Sinan Karacabey, Erkman Sanrı, Özge Ecmel Onur, Arzu Denizbaşı. ABO Blood Groups and Upper Gastrointestinal Bleeding: A Five-Year Retrospective Study. Abant Med J. 2025 Dec. 1;14(3):186-93. doi:10.47493/abantmedj.1752485